Lundbeck & Design

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Vienna Information

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information

Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and alcoholism addiction; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and alcoholism addiction; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and alcoholism addiction; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and alcoholism addiction; diagnostic reagents and agents for medical diagnostic use

Classification kind code

Mark Details

Serial Number

1791429

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 21^st Nov 2018	Allowed
Submitted for opposition 42 on 8^th Aug 2018	Advertised
Submitted for opposition 26 on 19^th Jul 2018	Approved
Submitted for opposition 27 on 31^st May 2018	Approval Notice Sent
Submitted for opposition 15 on 8^th Nov 2017	Correspondence Created
Submitted for opposition 22 on 7^th Feb 2017	Search Recorded
Submitted for opposition 20 on 7^th Feb 2017	Examiner's First Report
Submitted for opposition 31 on 20^th Jul 2016	Formalized
Submitted for opposition 1 on 15^th Jul 2016	Created
Submitted for opposition 30 on 14^th Jul 2016	Filed